Global Development Strategy for Generic Medicinal …
Global Development Strategy for Generic Medicinal Products with Regard to Bioequivalence Studies – Special Focus on the Biowaiver Approach in Canada, Australia and Brazil
Download Global Development Strategy for Generic Medicinal …
Information
Domain:
Source:
Link to this page:
Documents from same domain
The new Clinical Trial Regulation and corresponding …
dgra.deCAP Centrally Authorised Product . CEN Comité Européen de Normalisation, European Committee for Standardisation . CENELEC Comité Européen de Normalisation Électrotechnique, European Committee for
Labelling Requirements for Investigational …
dgra.deLabelling Requirements for Investigational Medicinal Products in Multinational Clinical Trials: Bureaucratic Cost Driver or Added Value? Wissenschaftliche Prüfungsarbeit
REGULATORY STRATEGIES AND PRACTICAL …
dgra.deregulatory strategies and practical aspects for the development and authorisation of orphan medicinal products in the european union wissenschaftliche prüfungsarbeit
Forced degradation studies – comparison between …
dgra.deForced degradation studies – comparison between ICH, EMA, FDA and WHO guidelines and ANVISA’s resolution RDC 53/2015 Wissenschaftliche Prüfungsarbeit
Best practice of worldwide product variations …
dgra.deBest practice of worldwide product variations regarding planning, conduct and implementation Wissenschaftliche Prüfungsarbeit zur Erlangung des Titels
Regulatory requirements of Medical Devices in …
dgra.deVII List of Abbreviations AHWP Asian Harmonization Working Party AMC Authorization for Market Commercialization APEC Asia Pacific Economic Cooporation
Standard for Outcome Measures in Clinical Trials for …
dgra.deStandard for Outcome Measures in Clinical Trials for the treatment of plaque psoriasis supporting Labelling Claim and their application in practice
Animal Health market in the BRIC countries and …
dgra.deList of Abbreviations 1 List of Abbreviations ACFTA ASEAN-China Free Trade Agreement AH Animal Health
EMA versus US-FDA regulatory requirements …
dgra.deEMA versus US-FDA regulatory requirements regarding bioequivalence of orally administered generics Wissenschaftliche Prüfungsarbeit zur Erlangung des Titels "Master of Drug Regulatory Affairs"
Development of Generic Oral Human Medicinal …
dgra.deDevelopment of Generic Oral Human Medicinal Products Suitable for the Registration in the EU as well as the USA – Different Requirements, Feasibility, Time and Cost
Related documents
GUIDELINES FOR BIOAVAILABILITY & …
www.cdsco.nic.inGUIDELINES FOR BIOAVAILABILITY & BIOEQUIVALENCE STUDIES Central Drugs Standard Control Organization, Directorate General of Health Services, Ministry of Health & Family Welfare,
Guideline for Bioequivalence Studies of Generic …
www.nihs.go.jp1 English translation of Attachment 1 of Division-Notification 0229 No. 10 of the Pharmaceutical and Food Safety Bureau, dated February 29, 2012 Guideline for Bioequivalence Studies of Generic Products
COMPARISON OF DISSOLUTION PROFILES: …
www.sefig.comDocencia 507 COMPARISON OF DISSOLUTION PROFILES: CURRENT GUIDELINES A.Prior, P.Frutos, C.P.Correa Dpto. Farmacia y Tecnología Farmacéutica, Facultad de …
Annex 9 - WHO
www.who.int441 Bioequivalence studies should be performed in compliance with the general regulatory requirements and recommendations on good practices as speci-
PROPOSAL TO WAIVE IN VIVO BIOEQUIVALENCE …
www.who.intWorking document QAS/04.109/Rev.1 page 4 local usage of the API, as to whether generic formulations should be subjected to in vivo bioequivalence (BE) studies or whether a Biowaiver can be applied.